(E)-6-((2-Amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one

Catalog No. :
ACBUVV922
CAS No. :
2230496-80-5
Molecular Formula :
C16H16N4O2
Molecular Weight :
296.33

IUPAC Name:(E)-6-((2-amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one

(E)-6-((2-Amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$181.00Login to see priceInquiryInquiry
10mg99%$271.00Login to see priceInquiryInquiry
25mg99%$472.00Login to see priceInquiryInquiry
50mg99%$705.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-6-((2-Amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one
IUPAC Name(E)-6-((2-amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one
Molecular FormulaC16H16N4O2
Molecular Weight296.33
SMILESO=C1NC2=C(C=C(/N=N/C3=CC(C)=C(O)C=C3N)C=C2)CC1
InChI KeyANMQADUROYWADA-FMQUCBEESA-N
Synonym2(1H)-Quinolinone, 6-[(1E)-2-(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-;6-[(1E)-2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-1,2,3,4-tetrahydroquinolin-2-one;(E)-ZL0420
CAS No.2230496-80-5
PubChem CID137285011

Synthetic Route by SureRoute

1. ACBUVV922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFMVB469 route compound structure diagram
    ACFMVB4692835-95-2 In Stock
  4. Plus
  5. ACSMZQ734 route compound structure diagram
    ACSMZQ73422246-13-5 In Stock
  6. Then
  7. ACBUVV922 route product structure diagram
    ACBUVV9222230496-80-5
Inquiry

2. ACBUVV922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBUVV922 route product structure diagram
    ACBUVV9222230496-80-5
Inquiry

Comments (0)